Measuring Quality in Arthritis Care: Methods for Developing the Arthritis Foundation's Quality Indicator Set

Arthritis Care and Research

Volumn 51, Issue 2, 2004, Pages 193-202

  MacLean, Catherine H ^a   Saag, Kenneth G ^b   Solomon, Daniel H ^c   Morton, Sally C ^d   Sampsel, Sarah ^e   Klippel, John H ^e  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ARTHRITIS FOUNDATION   (United States)

Author keywords

Analgesics; Arthritis; Nonsteroidal antiinflammatory drugs; Process assessment; Quality indicators

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MISOPROSTOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLAMINE; PREDNISONE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; STEROID; UNCLASSIFIED DRUG; VACCINE;

ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE QUALITY; HUMAN; KIDNEY DISEASE; LIVER TOXICITY; OSTEOARTHRITIS; PAIN; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RHEUMATOID ARTHRITIS; TERATOGENICITY;

EID: 1842780872     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20248     Document Type: Review

References (55)

1. Felson DT. The epidemiology of osteoarthritis: results from the Framingham osteoarthritis study. Semin Arthritis Rheum 1990;20:42-50.
2. Hughes SL, Dunlop D. The prevalence and impact of arthritis in older persons. Arthritis Care Res 1995;8:257-64.
3. Hughes SL, Edelman P, Chang RW, Singer RH, Schuette P. The GERI-AIMS: reliability and validity of the Arthritis Impact Measurement Scales adapted for elderly respondents. Arthritis Rheum 1991;34:856-65.
4. Verbrugge LM, Lepkowski JM, Konkol LL. Levels of disability among U.S. adults with arthritis. J Gerontol 1991;46:S71-83.
5. Yelin EH, Katz PP. Transitions in health status among community-dwelling elderly people with arthritis. Arthritis Rheum 1990;33:1205-15.
6. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
7. Bendor R. Arthritis and I. Ann Intern Med 1999;131:150-2.
8. Katz P. The impact of rheumatoid arthritis on life activities. Arthritis Care Res 1995;8:272-8.
9. Yelin E, Lubeck D, Holman H, Epstein W. The impact of rheumatoid arthritis and osteoarthritis: the activities of patients with rheumatoid arthritis and osteoarthritis compared to controls. J Rheumatol 1987;14:710-7.
10. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and causes of death in rheumatoid arthritis: a 25 year prospective follow-up. J Rheumatol 1984;11:158-61.
11. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
12. Rasker JJ, Cosh JA. Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 1981;40:115-20.
13. Lewis P, Hazelman BL, Hanka R, Roberts S. Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis 1980;39:457-61.
14. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
15. Monson RR, Hall AP. Mortality among arthritis. J Chronic Dis 1976;29:459-67.
16. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:846-72.
17. Escalante A, Barrett J, del Rincon I, Cornell JE, Phillips CB, Katz, JN. Disparity in total hip replacement affecting Hispanic Medicare beneficiaries. Med Care 2002;40:451-60.
18. Katz JN. Preferences, quality, and the (under)utilization of total joint arthroplasty. Med Care 2001;39:203-5.
19. Suarez-Almazor ME. Unraveling gender and ethnic variation in the utilization of elective procedures: the case of total joint replacement. Med Care 2002;40:447-50.
20. Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B, Glazier R, et al. Determining the need for hip and knee arthroplasty: the role of clinical severity and patients' preferences. Med Care 2001;39:206-16.
21. Griffiths RI, Bar-Din M, MacLean CH, Sullivan EM, Herbert RJ, Yelin EH. Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy. Arthritis Care Res 2000;13:213-26.
22. Ludig A, Guillemin F, Chary-Valckenaere I, Suurmeijer TP, Moum T, van den Heuvel WJ. Drug consumption in the first years of rheumatoid arthritis in France, The Netherlands, and Norway: a longitudinal study in the early nineties. Scand J Rheumatol 2000;26:352-7.
23. Berard A, Solomon DH, Avorn J. Patterns of drug use in rheumatoid arthritis. J Rheumatol 2000;27:1648-55.
24. Freund D, Dittus R. Assessing and improving outcomes: Total knee replacement Patient Outcomes Research Team (PORT). Final Report. AHCPR Publication No. 97-N015 Rockville (MD): Agency for Healthcare Policy and Research; 1995.
25. Katz BP, Freund DA, Heck DA, Dittus RS, Paul JE, Wright J, et al. Demographic variation in the rate of knee replacement: a multi-year analysis. Health Serv Res 1996;31:125-40.
26. Hocherg MC, Perlmutter DL, Hudson JI, Altman RD. Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the United States. Arthritis Care Res 1996;9:170-6.
27. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
28. Ward M, Leigh J, Fries J. Progression of functional disability in patients with rheumatoid arthritis: associations with rheumatology subspecialty care. Arch Intern Med 1993;153:2229-37.
29. Ward M, Lubeck D, Leigh J. Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. J Rheum 1998;25:641-9.
30. Yelin E, Such C, Criswell L, Epstein W. Outcomes for persons with rheumatoid arthritis with a rheumatologist versus nonrheumatologist as the main physician for this condition. Med Care 1998;36:513-22.
31. Kiefe CI, Allison JJ, Williams OD, Person SD, Weaver MT, Weissman NW. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA 2001;285:2871-9.
32. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 1995;311:793-6.
33. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed appropriateness of medical technologies. Int J Technol Assess Health Care 1986;2:53-63.
34. Brook R. The RAND/UCLA appropriateness method. In: Methodology perspectives, AHCPR Pub. No. 95-0009. Rockville (MD): Agency for Healthcare Policy and Research; 1994. p. 59-70.
35. Shekelle PG, Chassin MR, Park RE. Assessing the predictive validity of the RAND/UCLA appropriateness method criteria for performing cartoid endarterectomy. Int J Technol Assess Health Care 1998;14:707-27.
36. Kravitz RL, Laouri M, Kahan JP, Guzy P, Sherman T, Hilborne L, et al. Validity of criteria used for detecting underuse of coronary revascularization. JAMA 1995;274:632-8.
37. Selby JV, Fireman BH, Lundstrom RJ, Swain BE, Truman AF, Wong CC, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 1996;335:1888-96.
38. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Assessing the care of vulnerable elders: methods for developing quality indicators. Ann Intern Med 2001;135:647-52.
39. Park RE, Fink A, Brook RH, Chassin MR, Kahn KL, Merrick NJ, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health 1986; 76:766-72.
40. MacLean CH. Quality indicators for the management of osteoarthritis in vulnerable elders. Ann Intern Med 2001;135:711-21.
41. Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. J R Coll Physicians Lond 1992;26:76-82.
42. Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. Guidelines and a proposed audit protocol for the initial management of an acute hot joint. J R Coll Physicians Lond 1992; 26:83-5.
43. Coronary artery bypass surgery in New York State: 1994-1995. Albany: New York State Department of Health; 1995.
44. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-22.
45. Brook RH. Quality: can we measure it. N Engl J Med 1977; 296:170-2.
46. Weiner J, Parente S, Garnick D, Fowles J, Lawthers A, Palmer R. Variation in office-based quality: a claims-based profile of care provided to Medicare patients with diabetes. JAMA 1995;273:1503-8.
47. NCQA. Measuring the quality of America's health care. URL: www.ncqa.org. 1999.
48. McCarthy B, Yood M, McWilliams C, Lee M. Screening mammography use: the importance of a population perspective. Am J Prev Med 1996;12:91-5.
49. Katz S, Hofer T. Socioeconomic disparities in preventive care persist despite universal coverage: breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272: 530-4.
50. Ives D, Lave J, Traven N, Schulz R, Kuller L. Mammography and pap smear use by older rural women. Public Health Rep 1996;111:244-50.
51. Anderson L, May D. Has the use of cervical, breast and colorectal cancer screening increased in the United States? Am J Public Health 1995;85:840-2.
52. Schoenbaum M, Unutzer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001;286:1325-30.
53. Holman WL, Allman RM, Sansom M, Kiefe CI, Peterson ED, Anstrom KJ, et al. Alabama coronary artery bypass grafting project: results of a statewide quality improvement initiative. JAMA 2001;285:3003-10.
54. Donabedian A. The definition of quality: a conceptual exploration. In: The definition of quality and approaches to its assessment. Ann Arbor (MI): Health Administration Press 1980; p.1-32.
55. Lohr K, Schroeder S. A strategy for quality assurance in Medicare. N Engl J Med 1990;322:707-12.